• Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Most cited articles *

 
 
  Archives   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
MINI REVIEWS
Stemness-related markers in cancer
Wenxiu Zhao, Yvonne Li, Xun Zhang
May-June 2017, 3(3):87-95
DOI:10.4103/ctm.ctm_69_16  
  31 4,932 673
REVIEWS
BCL2 Family, Mitochondrial Apoptosis, and Beyond
Haiming Dai, X Wei Meng, Scott H Kaufmann
January-February 2016, 2(1):7-20
DOI:10.4103/2395-3977.177558  
  23 14,705 1,492
Senescence and Cancer
Sulin Zeng, Wen H Shen, Li Liu
May-June 2018, 4(3):70-74
DOI:10.4103/ctm.ctm_22_18  
  19 3,452 457
Systematic Review of MicroRNAs and its Therapeutic Potential in Glioma
Nan Liu, Yanyang Tu
March-April 2015, 1(2):50-66
DOI:10.4103/2395-3977.155924  
  13 5,245 668
The Potential of Wnt Signaling Pathway in Cancer: A Focus on Breast Cancer
Mahnaz M Kazi, Trupti I Trivedi, Toral P Kobawala, Nandita R Ghosh
March-April 2016, 2(2):55-60
DOI:10.4103/2395-3977.181437  
  13 5,843 966
ORIGINAL ARTICLES
SKI-178: A multitargeted inhibitor of sphingosine kinase and microtubule dynamics demonstrating therapeutic efficacy in acute myeloid leukemia models
Jeremy A Hengst, Taryn E Dick, Arati Sharma, Kenichiro Doi, Shailaja Hegde, Su-Fern Tan, Laura M Geffert, Todd E Fox, Arun K Sharma, Dhimant Desai, Shantu Amin, Mark Kester, Thomas P Loughran, Robert F Paulson, David F Claxton, Hong-Gang Wang, Jong K Yun
July-August 2017, 3(4):109-121
DOI:10.4103/ctm.ctm_7_17  
  11 3,249 423
ORIGINAL ARTICLE
Implications of Circadian Rhythm Regulation by microRNAs in Colorectal Cancer
Song Wu, Andrew Fesler, Jingfang Ju
January-February 2016, 2(1):1-6
DOI:10.4103/2395-3977.177555  
  10 3,323 467
MINI REVIEWS
Autophagy regulated by miRNAs in colorectal cancer progression and resistance
Andrew Fesler, Hua Liu, Ning Wu, Fei Liu, Peixue Ling, Jingfang Ju
May-June 2017, 3(3):96-100
DOI:10.4103/ctm.ctm_64_16  
  9 3,563 398
REVIEW
“Eating” Cancer cells by blocking CD47 signaling: Cancer therapy by targeting the innate immune checkpoint
Yi-Rong Xiang, Li Liu
November-December 2017, 3(6):200-208
DOI:10.4103/ctm.ctm_26_17  
  9 6,270 930
REVIEWS
Promoter Methylated Tumor Suppressor Genes in Glioma
Yingduan Cheng, Yanyang Tu, Pei Liang
July-August 2015, 1(4):123-130
DOI:10.4103/2395-3977.163803  
  9 3,766 505
ORIGINAL ARTICLE
Novel molecular multilevel targeted antitumor agents
Poonam Sonawane, Young A Choi, Hetal Pandya, Denise M Herpai, Izabela Fokt, Waldemar Priebe, Waldemar Debinski
May-June 2017, 3(3):69-79
DOI:10.4103/ctm.ctm_12_17  
  8 2,917 397
REVIEWS
Functional Perspective and Implications of Gene Expression by Noncoding RNAs
Xiaoshuang Yan, Huanyu Xu, Zhonghai Yan
July-August 2015, 1(4):137-152
DOI:10.4103/2395-3977.163805  
  8 3,535 393
Histone H2A and H2B Deubiquitinase in Developmental Disease and Cancer
Demeng Chen, Caifeng Dai, Yizhou Jiang
September-October 2015, 1(5):170-175
DOI:10.4103/2395-3977.168578  
  7 3,941 501
ORIGINAL ARTICLE
Etiological Trends in Oral Squamous Cell Carcinoma: A Retrospective Institutional Study
Varsha Salian, Chethana Dinakar, Pushparaja Shetty, Vidya Ajila
March-April 2016, 2(2):33-36
DOI:10.4103/2395-3977.181429  
  6 5,812 798
Mutation detection with a liquid biopsy 96 mutation assay in cancer patients and healthy donors
Aaron Yun Chen, Glenn D Braunstein, Megan S Anselmo, Jair A Jaboni, Fernando Troy Viloria, Julie A Neidich, Xiang Li, Anja Kammesheidt
March-April 2017, 3(2):39-45
DOI:10.4103/2395-3977.202228  
  6 3,291 446
ORIGINAL ARTICLES
Galanin is a novel epigenetic silenced functional tumor suppressor in renal cell carcinoma
Shengkun Sun, Axiang Xu, Guoqiang Yang, Yingduan Cheng
November-December 2015, 1(6):183-187
DOI:10.4103/2395-3977.172861  
  6 2,917 4,589
MINI REVIEW
Melanoma Antigen Gene Family in the Cancer Immunotherapy
Fengyu Zhu, Yu Liang, Demeng Chen, Yang Li
May-June 2016, 2(3):85-89
DOI:10.4103/2395-3977.184320  
  5 3,577 467
MINI REVIEWS
The role of reactive oxygen species in screening anticancer agents
Xiaohui Xu, Zilong Dang, Taoli Sun, Shengping Zhang, Hongyan Zhang
January-February 2018, 4(1):35-38
DOI:10.4103/ctm.ctm_6_18  
  5 2,283 334
ORIGINAL ARTICLES
A T-cell engager-armed oncolytic vaccinia virus to target the tumor stroma
Feng Yu, Bangxing Hong, Xiao-Tong Song
July-August 2017, 3(4):122-132
DOI:10.4103/ctm.ctm_13_17  
  5 3,826 450
REVIEWS
Nanoparticle drug delivery systems and three-dimensional cell cultures in cancer treatments and research
Wenjin Shi, Ding Weng, Wanting Niu
September-October 2016, 2(5):154-161
DOI:10.4103/2395-3977.192933  
  5 3,754 703
MicroRNA regulating metabolic reprogramming in tumor cells: New tumor markers
Daniel Otero-Albiol, Blanca Felipe-Abrio
November-December 2016, 2(6):175-181
DOI:10.4103/2395-3977.196909  
  5 3,323 1,531
MINI REVIEW
CD24 as a Molecular Marker in Ovarian Cancer: A Literature Review
Lu Huang, Weiguo Lv, Xiaofeng Zhao
January-February 2016, 2(1):29-32
DOI:10.4103/2395-3977.177563  
  4 4,413 638
ORIGINAL ARTICLE
Correlation between paclitaxel Tc > 0.05 and its therapeutic efficacy and severe toxicities in ovarian cancer patients
Shuyao Zhang, Muyin Sun, Yun Yuan, Miaojun Wang, Yuqi She, Li Zhou, Congzhu Li, Chen Chen, Shengqi Zhang
September-October 2016, 2(5):131-136
DOI:10.4103/2395-3977.192930  
  4 2,646 363
REVIEWS
Palliative Treatment of Malignant Pleural Effusion
Chenyang Liu, Qian Qian, Shen Geng, Wenkui Sun, Yi Shi
July-August 2015, 1(4):131-136
DOI:10.4103/2395-3977.163804  
  4 22,994 1,114
The Role of Precision Medicine in Pancreatic Cancer: Challenges for Targeted Therapy, Immune Modulating Treatment, Early Detection, and Less Invasive Operations
Khaled Kyle Wong, Zhirong Qian, Yi Le
March-April 2016, 2(2):41-47
DOI:10.4103/2395-3977.181434  
  3 5,063 818
* Source: CrossRef